DXN Holdings Bhd. (KLSE:DXN)

Market Cap	2.29B -8.0%
Revenue (ttm)	1.93B -0.3%
Net Income	271.52M -17.2%
EPS	0.05 -17.2%
Shares Out	4.97B
PE Ratio	8.42
Forward PE	7.24
Dividend	0.03 (7.19%)
Ex-Dividend Date	May 13, 2026

Volume	4,936,400
Open	0.4450
Previous Close	0.4450
Day's Range	0.4400 - 0.4600
52-Week Range	0.4250 - 0.5500
Beta	0.23
Analysts	Buy
Price Target	0.58 (+26.09%)
Earnings Date	May 29, 2026

About DXN Holdings Bhd.

DXN Holdings Bhd. manufactures and sales health supplements and other products on direct sales basis in Latin America, Malaysia, Asia, North America, Africa, Europe, the Middle East, and Oceania. It offers coffee, tea, nutritious drinks, juices, confectionery and biscuits, herbs, mushrooms and fungi, premixes, toothpastes, face masks, perfumes, body foams, shampoos, soaps, powders, travel kits, toothbrushes, sanitizers, massage and baby oil, lipsticks, finish powders, and scrubs. The company also operates cafes, glamping resort, tourism village...

• Industry: Pharmaceutical Preparations
• Founded: 1993
• Employees: 3,489
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: DXN

Financial Performance

In fiscal year 2026, DXN Holdings Bhd.'s revenue was 1.93 billion, a decrease of -0.33% compared to the previous year's 1.94 billion. Earnings were 271.52 million, a decrease of -17.24%.

Analyst Summary

According to 3 analysts, the average rating for DXN stock is "Buy." The 12-month stock price target is RM 0.58, which is an increase of 26.09% from the latest price.

Price Target

RM 0.58

(26.09% upside)

Analyst Consensus: Buy